Base case results of an analysis of hypothetical HIV cure strategies^*.

*Based on assumptions for efficacy, durability, toxicity, and cost in Methods and Table 1. Life expectancy, QALYs, and costs all discounted at 3%/year. ART: antiretroviral therapy; QALY: Quality-adjusted life year; Dominated: Less effective and more costly than the standard of care ART strategy. Base case results of an analysis of hypothetical HIV cure strategies*.